CWM
ABBV icon

CarsonAllaria Wealth Management’s AbbVie ABBV Stock Holding History

CarsonAllaria Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-132
Closed -$24.6K – 70
2025
Q2 		$24.6K Buy
132
+1
+0.8% +$186 0.01% 180
2025
Q1 		$27.5K Buy
131
+1
+0.8% +$194 0.02% 171
2024
Q4 		$23.1K Buy
130
+1
+0.8% +$184 0.01% 187
2024
Q3 		$25.7K Buy
129
+1
+0.8% +$187 0.01% 186
2024
Q2 		$22.1K Buy
128
+1
+0.8% +$166 0.01% 188
2024
Q1 		$23.2K Buy
127
+1
+0.8% +$172 0.01% 183
2023
Q4 		$19.6K Buy
126
+1
+0.8% +$146 0.01% 172
2023
Q3 		$18.7K Buy
125
+1
+0.8% +$147 0.02% 167
2023
Q2 		$16.7K Buy
124
+2
+2% +$293 0.01% 183
2023
Q1 		$19.6K Buy
122
+1
+0.8% +$153 0.02% 169
2022
Q4 		$20K Buy
121
+1
+0.8% +$153 0.02% 151
2022
Q3 		$16K Buy
120
+1
+0.8% +$143 0.01% 156
2022
Q2 		$18K Sell
119
-2
-2% -$306 0.02% 150
2022
Q1 		$20K Sell
121
-42
-26% -$6.1K 0.02% 160
2021
Q4 		$22K Buy
+163
New +$19.3K 0.02% 168

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CarsonAllaria Wealth Management's ABBV Position: Q3 2025 in Review

CarsonAllaria Wealth Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 132 shares — an estimated $24.6K sold.

CarsonAllaria Wealth Management first reported a position in ABBV in Q4 2021 and held it in 15 quarters. The position peaked at $27.5K in Q1 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • CarsonAllaria Wealth Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 132 AbbVie shares in Q3 2025, an estimated $24.6K.
  • CarsonAllaria Wealth Management first reported a position in AbbVie in Q4 2021 and held it in 15 quarters.
  • CarsonAllaria Wealth Management's AbbVie position peaked at $27.5K in Q1 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.